Infertility
Conditions
Interventions
Treatment Plan for Ganirelix Acetate Injection:No
Sponsors
Hospital for Reproductive Medicine Affiliated to Shandong University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1) Voluntarily sign an informed consent form; 2) Female, aged 18-45 years (including 18 and 45 years old); 3) Patients who have been evaluated by a physician to use a gonadotropin releasing hormone antagonist regimen for ovulation induction in assisted reproductive technology treatment; 4) Patients who voluntarily join this project and are fully aware of it;
Exclusion criteria
Exclusion criteria: 1) Patients with mental disorders or disabilities; 2) The patient has undergone surgical treatment within the past month; 3) The patient had infectious diseases, serious heart, liver and brain diseases, and malignant tumors; 4) Patients who have poor compliance or may not be able to complete the project, according to the physician of the research group; 5) The patient did not undergo embryo transfer more than six months after egg retrieval; 6) Participated in clinical research on other projects within 3 months prior to signing the informed consent form;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ongoing Pregnancy Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of retrieved oocytes;Number of high-quality embryos;Dose of gonadotropin use;Cycle cancellation rate;Clinical Pregnancy Rate;Live Birth Rate; | — |
Countries
China
Contacts
Public ContactZijiang Chen
Hospital for Reproductive Medicine Affiliated to Shandong University
Outcome results
None listed